Google CEO Sundar Pichai speaks at a panel at the CEO Summit of the Americas hosted by the U.S. Chamber of Commerce on June 09, 2022 in Los Angeles, California.
Anna Moneymaker | Getty Images
Google and Alphabet CEO Sundar Pichai said “every product of every company” will be impacted by the quick development of AI, warning that society needs to prepare for technologies like the ones it’s already launched.
In an interview with CBS’ “60 Minutes” aired on Sunday that struck a concerned tone, interviewer Scott Pelley tried several of Google’s AI projects and said he was “speechless” and felt it was “unsettling,” referring to the human-like capabilities of products like Google’s chatbot Bard.
“We need to adapt as a society for it,” Pichai told Pelley, adding that jobs that would be disrupted by AI would include “knowledge workers,” including writers, accountants, architects and, ironically, even software engineers.
“This is going to impact every product across every company,” Pichai said. “For example, you could be a radiologist, if you think about five to ten years from now, you’re going to have an AI collaborator with you. You come in the morning, let’s say you have a hundred things to go through, it may say, ‘these are the most serious cases you need to look at first.'”
Pelley viewed other areas with advanced AI products within Google, including DeepMind, where robots were playing soccer, which they learned themselves, as opposed to from humans. Another unit showed robots that recognized items on a countertop and fetched Pelley an apple he asked for.
When warning of AI’s consequences, Pichai said the scale of the problem of disinformation and fake news and images will be “much bigger,” adding that “it could cause harm.”
Last month, CNBC reported that internally, Pichai told employees that the success of its newly launched Bard program now hinges on public testing, adding that “things will go wrong.”
Google launched its AI chatbot Bard as an experimental product to the public last month. It followed Microsoft’s January announcement that its search engine Bing would include OpenAI’s GPT technology, which garnered international attention after ChatGPT launched in 2022.
However, fears of the consequences of the rapid progress has also reached the public and critics in recent weeks. In March, Elon Musk, Steve Wozniak and dozens of academics called for an immediate pause in training “experiments” connected to large language models that were “more powerful than GPT-4,” OpenAI’s flagship LLM. Over 25,000 people have signed the letter since then.
“Competitive pressure among giants like Google and startups you’ve never heard of is propelling humanity into the future, ready or not,” Pelley commented in the segment.
Google has launched a document outlining “recommendations for regulating AI,” but Pichai said society must quickly adapt with regulation, laws to punish abuse and treaties among nations to make AI safe for the world as well as rules that “Align with human values including morality.”
“It’s not for a company to decide,” Pichai said. “This is why I think the development of this needs to include not just engineers but social scientists, ethicists, philosophers, and so on.”
When asked whether society is prepared for AI technology like Bard, Pichai answered, “On one hand, I feel no, because the pace at which we can think and adapt as societal institutions, compared to the pace at which the technology is evolving, there seems to be a mismatch.”
However, he added that he’s optimistic because compared with other technologies in the past, “the number of people who have started worrying about the implications” did so early on.
From a six word prompt by Pelley, Bard created a tale with characters and plot that it invented, including a man who’s wife couldn’t conceive and a stranger grieving after a miscarriage and longing for closure. “I am rarely speechless,” Pelley said. “The humanity at super human speed was a shock.”
Pelley said he asked Bard why it helps people and it replied “because it makes me happy,” which Pelley said shocked him. “Bard appears to be thinking,” he told James Manyika, a SVP Google hired last year as head of “technology and society.” Manyika responded that Bard is not sentient and not aware of itself but it can “behave like” it.
Pichai also said Bard has a lot of hallucinations after Pelley explained that he asked Bard about inflation and received an instant response with suggestions for five books that, when he checked later, didn’t actually exist.
Pelley also seemed concerned when Pichai said there is “a black box” with chatbots, where “you don’t fully understand” why or how it comes up with certain responses.
“You don’t fully understand how it works and yet you’ve turned it loose on society?” Pelley asked.
“Let me put it this way, I don’t think we fully understand how a human mind works either,” Pichai responded.
After posting almost 200 videos, amassing hundreds of thousands of followers and racking up millions of views, Carla Lalli Music is quitting YouTube. Substack is her new focus.
Music is a cookbook author and food content creator, and she is shifting her focus to Substack, a subscription platform that lets creators charge users subscriptions for access to their content. Music told CNBC she came to that decision after earning more in one year of using Substack, nearly $200,000 in revenue, than she did by posting videos on YouTube since 2021.
Music is the exact kind of content creator that Substack is trying to lure to its platform as TikTok’s future in the U.S. remains in limbo.
San Francisco-based Substack launched in 2017 as a tool for newsletter writers to charge readers a monthly fee to read their content. The platform allows creators to connect to their followers directly without having to navigate algorithmic models that control when their content is shown, as is the case on TikTok, Google’s YouTube and other social platforms. Substack has raised about $100 million, most recently at a post-money valuation of more than $650 million, the company told CNBC.
This year, Substack has broadened its focus beyond newsletters, and on Thursday, it announced that creators can now post video content directly through the Substack app and monetize these videos.
“There’s going to be a world of people who are much more focused on videos,” Substack Co-founder Hamish McKenzie told CNBC. “That is a huge world that Substack is only starting to penetrate.”
Substack began this push after the social media landscape was thrown into flux as a result of the effective ban of TikTok in January that caused the popular Chinese-owned service to go offline for a few hours. TikTok was also removed from Apple and Google’s app stores for nearly a month.
The disruption to TikTok in January happened as a result of a law signed by former President Joe Biden to force a sale of the Chinese-owned app or have it effectively banned in the U.S. On his first day in office, President Donald Trump signed an executive order extending TikTok’s ability to operate in the U.S., but that order expires on April 5.
Days after TikTok went offline, Substack launched a $20 million fund to court creators to its platform.
“If TikTok gets banned for political reasons, there’s nothing to do with the work you’ve done, but it really affects your life,” McKenzie said. “The only and surefire guard against that is if you don’t place your audience in the hands of some other volatile system who doesn’t care about what happens to your livelihood.”
Moving beyond newsletters
McKenzie says that they are going after creators on competing social media platforms to start sharing their video content on Substack.
“Video-first creators, people who are mobile oriented, there’s a whole lot of new possibility waiting to be unlocked once they meet this model in the right place,” McKenzie said.
Already, Substack has more than 4 million paid subscriptions with over 50,000 creators who make money on the platform, the company said. Substack says that 82% of its top 250 revenue-generating creators have already integrated audio or video into their content, reflecting a growing emphasis on multimedia content.
Prior to the video announcements, Substack allowed creators to post videos on the app to Notes, which is the platform’s front-facing feed format. But the feature did not allow creators to publish video content behind Substack’s paywalls.
The update enables creators to put video content behind a paywall and it provides data on estimated revenue impact. It also allows them to track viewership and new subscribers.
Carla Lalli Music is a cookbook writer and food creator.
Carla Lalli Music
The push by Substack into video is a welcomed development for creators like Music, who was losing money from making videos for YouTube.
Music said each video costs her $3,500 to produce despite filming at home. If she published four videos a month on YouTube, she’d earn about $4,000 in revenue. Music was losing about $10,000 a month, she said.
“It’s really depressing to operate at a loss,” said Music.
Even with brand deals, which is an agreement where brands pay creators to post content that promotes their products, the earnings were barely enough to recoup the costs of posting on YouTube, Music said.
More than half of the $290 billion creator economy comes from direct-to-fan value. That includes ticket sales, courses, livestreams and paid memberships, according to a survey conducted by Patreon, a Substack competitor.
With her shift to Substack, Music said she’s now focused on writing another book, posting recipes behind the platform’s paywall and sprinkling in occasional videos.
“I have a lot more to benefit from focused attention on a smaller group of people than I ever did on throwing stuff and seeing what was going to stick with billions of potential audience members,” Music said. “It’s more sustainable.”
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023.
Kelly Sullivan | Getty Images Entertainment | Getty Images
23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and Exchange Commission.
Wojcicki and New Mountain have offered to acquire all of 23andMe’s outstanding shares in cash for $2.53 per share, or an equity value of approximately $74.7 million. The company’s stock closed at $2.42 on Friday with a market cap of about $65 million.
The offer comes after a turbulent year for 23andMe, with the stock losing more than 80% of its value in 2024. In January, the company announced plans to explore strategic alternatives, which could include a sale of the company or its assets, a restructuring or a business combination.
Read more CNBC tech news
23andMe has a special committee of independent directors in place to evaluate potential paths forward. The company appointed three new independent directors to its board in October after all seven of its previous directors abruptly resigned the prior month. The special committee has to approve Wojcicki and New Mountain’s proposal.
“We believe that our Proposal provides compelling value and immediate liquidity to the Company’s public stockholders,” Wojcicki and Matthew Holt, managing director and president of private equity at New Mountain, wrote in a letter to the special committee on Thursday.
Wojcicki previously submitted a proposal to take the company private for 40 cents per share in July, but it was rejected by the special committee, in part because the members said it lacked committed financing and did not provide a premium to the closing price at the time.
Wojcicki and New Mountain are willing to provide secured debt financing to fund 23andMe’s operations through the transaction’s closing, the filing said. New Mountain is based in New York and has $55 billion of assets under management, according to its website.
Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved.
Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been prescribing compounded semaglutide as an alternative for patients who are navigating volatile supply hurdles and insurance obstacles.
Compounded drugs are custom-made alternatives to brand-name drugs designed to meet a specific patient’s needs, and compounders are allowed to produce them when brand-name treatments are in shortage. The FDA doesn’t review the safety and efficacy of compounded products.
Hims & Hers began offering compounded semaglutide to patients in May, and it owns compounding pharmacies that produce the medications.
Compounded medications are typically much cheaper than their branded counterparts. Hims & Hers sells compounded semaglutide for less than $200 per month, while Ozempic and Wegovy both cost around $1,000 per month without insurance.
Read more CNBC tech news
The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days, depending on the type of facility, in order to “avoid unnecessary disruption to patient treatment.”
“Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO Andrew Dudum posted Friday on X. “We’re also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have ‘capacity limitations’ and ‘expected continued periodic supply constraints and related drug shortage notifications.'”
Him & Hers’ weight loss offerings have been a massive hit with investors. Shares of the company climbed more than 200% last year, and the stock is already up more than 100% this year despite Friday’s move.
Even before it added compounded GLP-1s to its portfolio, the company said in its 2023 fourth-quarter earnings call that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025.
Despite the turbulent regulatory landscape, Hims & Hers has showed no signs of slowing down.
On Friday, the company announced it has acquired a U.S.-based peptide facility that will “further verticalize the company’s long-term ability to deliver personalized medications.” Hims & Hers will explore advances across metabolic optimization, recovery science, biological resistances, cognitive performance and preventative health through the acquisition, the company said.
That move comes just days after Hims & Hers also bought Trybe Labs, the New Jersey-based at-home lab testing facility. Trybe Labs will allow Hims & Hers to perform at-home blood draws and more comprehensive pretreatment testing.
Hims & Hers did not disclose the terms of either deal.